Nguyen Anita, Schaff Hartzell V
Department of Cardiovascular Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Department of Cardiovascular Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Cardiol Clin. 2019 Feb;37(1):95-104. doi: 10.1016/j.ccl.2018.08.006. Epub 2018 Oct 31.
Surgical septal myectomy is the preferred method of septal reduction for most patients with obstructive hypertrophic cardiomyopathy whose symptoms do not respond to medical management. Transaortic extended septal myectomy has low operative mortality and provides durable relief of symptoms. Surgical treatment is possible for patients with less common phenotypes, such as complex long-segment septal hypertrophy, midventricular obstruction, or apical hypertrophic cardiomyopathy. For these anatomic subtypes, transapical myectomy can be used alone or combined with transaortic myectomy. This article describes both of these surgical techniques and discusses preoperative considerations and postoperative management for patients with hypertrophic cardiomyopathy.
对于大多数症状对药物治疗无反应的梗阻性肥厚型心肌病患者,外科室间隔心肌切除术是首选的间隔缩小方法。经主动脉扩大室间隔心肌切除术手术死亡率低,能持久缓解症状。对于不太常见表型的患者,如复杂的长节段间隔肥厚、心室中部梗阻或心尖肥厚型心肌病,也可行手术治疗。对于这些解剖亚型,经心尖心肌切除术可单独使用或与经主动脉心肌切除术联合使用。本文介绍了这两种手术技术,并讨论了肥厚型心肌病患者的术前注意事项和术后管理。